Año: 2022
Journal Impact Factor (JIF): 15,1
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| CRITICAL CARE MEDICINE | SCIE | 4/35 | Q1 | T1 | D2 |
Año: 2022
Journal Citation Indicator (JCI): 1,970
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| CRITICAL CARE MEDICINE | 4/53 | Q1 | T1 | D1 | 93,40 |
Año:
2022
CiteScore:
18,800
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Critical Care and Intensive Care Medicine | 3/100 | Q1 | T1 | D1 |
SJR año:
2022
Factor de Impacto:
3,577
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Critical Care and Intensive Care Medicine | 3/108 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| Bill & Melinda Gates Foundation | OPP1209135 |
| Cambridge NIHR Biomedical Research Centre | - |
| CIHR Coronavirus Rapid Research Funding Opportunity | OV2170359 |
| COVID clinical management team, AIIMS, Rishikesh, India | - |
| Endorsed by the Irish Critical Care-Clinical Trials Group | - |
| European Clinical Research Alliance on Infectious Diseases (ECRAID) | 965313 |
| Health Research Board of Ireland | CTN2014-12 |
| Imperial NIHR Biomedical Research Centre | - |
| Liverpool Experimental Cancer Medicine Centre | C18616/A25153 |
| Medical Research Council (MRC) | MC_PC_19059 |
| National Institute for Health Research (NIHR) | CO-CIN-01 |
| NIHR Biomedical Research Centre at Imperial College London | IS-BRC-1215-20013 |
| NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at the University of Liverpool | - |
| NIHR HPRU in Respiratory Infections at Imperial College London with PHE | 200927 |
| Public Health England (PHE) | 200907 |
| Rapid European COVID-19 Emergency Response research (RECOVER) [H2020 Project] | 101003589 |
| Research Council of Norway | 312780 |
| UK Foreign, Commonwealth, and Development Office | - |
| Wellcome | 215091/Z/18/Z |
| Wellcome Trust | 205228/Z/16/Z |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Universidad de La Sabana; University of Oxford (England) | |
| 2 | Murthy, S. | University of British Columbia (Canada) |
| 3 | García-Gallo, E. | Universidad de La Sabana (Colombia) |
| 4 | Merson, L. | University of Oxford (England) |
| 5 | Ibáñez-Prada, E. D. | Universidad de La Sabana (Colombia) |
| 6 | Rello, J. | Instituto de Salud Carlos III; Vall d'Hebron Institut de Recerca (VHIR) (Spain) |
| 7 | Fuentes, Y. V. | Universidad de La Sabana (Colombia) |
| 8 | Martín-Loeches, I. | Trinity College Dublin (Ireland) |
| 9 | Bozza, F. | Fundacao Oswaldo Cruz; IDOR - Instituto D'Or de Ensino e Pesquisa; Brazilian Res Intens Care Network BRICNet (Brazil) |
| 10 | Duque, S. | Universidad de La Sabana (Colombia) |
| 11 | Taccone, F. S. | Universite Libre de Bruxelles (Belgium) |
| 12 | Fowler, R. A. | University of Toronto (Canada) |
| 13 | Kartsonaki, C. | University of Oxford (England) |
| 14 | Gonçalves, B. P. | University of Oxford (England) |
| 15 | Citarella, B. W. | University of Oxford (England) |
| 16 | Aryal, D. | Nepal Mediciti Hosp (Nepal) |
| 17 | Burhan, E. | University of Indonesia (Indonesia) |
| 18 | Cummings, M. J. | Columbia University (USA) |
| 19 | Delmas, C. | Universite Paris Cite (France) |
| 20 | Díaz, R. | Clinica Las Condes (Chile) |
| 21 | Figueiredo-Mello, C. | Inst Infectol Emilio Ribas (Brazil) |
| 22 | Hashmi, M. | Crit Care Asia; Ziauddin University (Pakistan) |
| 23 | Panda, P. K. | All India Institute of Medical Sciences (AIIMS) Rishikesh (India) |
| 24 | Pedrera Jiménez, M. | Hospital Universitario 12 de Octubre (Spain) |
| 25 | BauRincon, D. F. | Fundación Valle del Lili (Colombia) |
| 26 | Thomson, D. | University of Cape Town (South Africa) |
| 27 | Nichol, A. | Saint Vincent's University Hospital (Ireland) |
| 28 | Marshall, J. C. | Saint Michaels Hospital Toronto (Canada) |
| 29 | Olliaro, P. L. | University of Oxford (England) |
| # | Autoría grupal | Afiliación |
| 1 | Cisneros, J. M. (ISARIC characterization group) | Sin datos () |
